1/2 Les pharmacologues suivent-ils de près le sujet des biomarqueurs "covid"? Que peut apporter aux médecins leur discipline, leur expertise, leur expérience, dans ce domaine ? @FlorianLemaitr5 @MARYau_MCU_PH @D_Deplanque @MathieuMolimard @micallef_joelle
821 followers
821 followers
COVID-19 #biomarkers : What did we learn from systematic reviews? "Thus, these parameters should be used as essential tools for an early risk stratification and adequate intervention in improving disease outcomes in #COVID19 patients." https://t.co/r7H
42 followers
COVID19 biomarkers: What did we learn from systematic reviews? https://t.co/5i6fP2pp4t https://t.co/nnuzdZevjk
537 followers
COVID19 biomarkers: What did we learn from systematic reviews? https://t.co/BhbNhIjtIu https://t.co/gKAAmTcRWW